1W Return
1M Return
6M Return
1Y Return
3Y Return
The current prices are delayed, login or open an account for live prices.
Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
37.82% Fall from 52W High
4.4
TTM PE Ratio
High in industry
84.9
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.6
RSI
RSI is mid-range
46.8
MFI
MFI is mid-range
39.2
Concord Drugs Ltd Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Concord Drugs Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
38.40
10Day EMA
38.60
12Day EMA
38.60
20Day EMA
38.70
26Day EMA
38.70
50Day EMA
38.60
100Day EMA
38.60
200Day EMA
37.90
5Day SMA
38.50
10Day SMA
38.60
20Day SMA
38.80
30Day SMA
38.90
50Day SMA
38.80
100Day SMA
37.90
150Day SMA
40.30
200Day SMA
39.10
Resistance & Support
38.36
Pivot
Resistance
First Resistance
39.08
Second Resistance
39.91
Third Resistance
40.63
Support
First Support
37.53
Second support
36.81
Third Support
35.98
Relative Strength Index
46.82
Money Flow Index
39.16
MACD
-0.10
MACD Signal
-0.01
Average True Range
2.20
Average Directional Index
24.26
Rate of Change (21)
-7.16
Rate of Change (125)
-7.43
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Veerhealth Care Ltd. | - | - | - | |
Phaarmasia Ltd. | - | - | - | |
Gujarat Terce Laboratories Ltd. | - | - | - | |
Zenith Healthcare Ltd. | - | - | - | |
Roopa Industries Ltd. | - | - | - | |
Concord Drugs Ltd. | - | - | - | |
Murae Organisor Ltd. | - | - | - |
Concord Drugs Ltd Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Ltd FAQs
How can I buy Concord Drugs Ltd shares?
You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
